Identifying pathogenic proteins leads to potential new treatments for diseases such as diabetes.

Published Date: 02 Mar 2023

New research has identified hundreds of proteins that can lead to the development of metabolic diseases, such as type 2 diabetes mellitus, and therefore have treatment potential.

Read Full News

Latest News

HCPLive 5 Stories in Under 5: Week of 01/11

HCPLive 5 Stories in Under 5: Week of 01/11

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

HCPLive 5 Stories in Under 5: Week of 01/04

HCPLive 5 Stories in Under 5: Week of 01/04

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

Todays Updates

Phase 3 Trial Supports Subcutaneous Anifrolumab in Systemic Lupus Erythematosus Chelsie Derman

Subcutaneous anifrolumab for SLE met its primary BICLA endpoint at 52 weeks and significantly increased DORIS-defined remission and low disease activity.

What the EC Decision on High-Dose Spinraza Means for SMA Care Marco Meglio, Stephanie Fradette, PhD

Stephanie Fradette, PharmD, head of neuromuscular development at Biogen, gave immediate reaction to the EC approval of high-dose nusinersen and its implications for evolving SMA treatment strategies.

Dopamine D3 Receptor Mesdopetam Maintains Antidyskinesia Effects Despite Failure to Improve Parkinson Disease ON Time Marco Meglio

A recent phase 2b study reveals mesdopetam's potential in reducing dyskinesia severity in Parkinson disease, despite no significant ON time improvement.

Todays Updates

Phase 3 Trial Supports Subcutaneous Anifrolumab in Systemic Lupus Erythematosus Chelsie Derman

Subcutaneous anifrolumab for SLE met its primary BICLA endpoint at 52 weeks and significantly increased DORIS-defined remission and low disease activity.

What the EC Decision on High-Dose Spinraza Means for SMA Care Marco Meglio, Stephanie Fradette, PhD

Stephanie Fradette, PharmD, head of neuromuscular development at Biogen, gave immediate reaction to the EC approval of high-dose nusinersen and its implications for evolving SMA treatment strategies.

Dopamine D3 Receptor Mesdopetam Maintains Antidyskinesia Effects Despite Failure to Improve Parkinson Disease ON Time Marco Meglio

A recent phase 2b study reveals mesdopetam's potential in reducing dyskinesia severity in Parkinson disease, despite no significant ON time improvement.

Latest News

HCPLive 5 Stories in Under 5: Week of 01/11

FDA Requests Removal of Suicidal Ideation and Behavior Warning From GLP-1 RA Therapies

ADA’s Obesity Association Releases Guidelines for Use of Obesity Medications

HCPLive 5 Stories in Under 5: Week of 01/04

FDA Clears MiniMed Go Smart MDI App for Adults and Children with T1D, T2D

The HCPFive: Top News for Healthcare Providers from the Week of 01/04

News All Time

Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD

Impacts of the Lancet Commission on Obesity Treatment, With Pooja Singhal, MD

Gestational Diabetes Linked to Reduced Lung Function in Children

Gestational Diabetes Linked to Reduced Lung Function in Children

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

GLP-1 RA Use Linked to 42% Hepatocellular Carcinoma Risk Reduction in T2DM

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

Orforglipron Maintains Weight Loss in Patients Switching from Semaglutide or Tirzepatide

5 Endocrinology Headlines You Missed in November 2025

5 Endocrinology Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

5 FDA Headlines You Missed in November 2025

Metformin Fails to Improve Insulin Resistance in Type 1 Diabetes

Metformin Fails to Improve Insulin Resistance in Type 1 Diabetes

Beyond Blood Sugar: Reframing Diabetes Awareness Through the Lens of Obesity

Beyond Blood Sugar: Reframing Diabetes Awareness Through the Lens of Obesity

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Semaglutide Provides Cardiorenal Benefits in CKD With or Without Diabetes

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Novo Nordisk’s Amycretin Demonstrates Superior Weight Loss Versus Placebo

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

Investigative Amylin Agonist Eloralintide Proves Superiority to Placebo in Weight Management

Evidence builds for disrupted mitochondria as cause of Parkinson's

For decades, scientists have known that mitochondria, which produce energy inside our cells, malfunction in Parkinson's disease. But a critical question remained: do the failing mitochondria cause Parkinson's, or do they ...

Keto diet associated with reduced depressive symptoms, anxiety results remain mixed

Researchers led by St Michael's Hospital in Toronto report that ketogenic diets are associated with modest reductions in depressive symptoms in adults, while evidence for anxiety remains uncertain.

Some women start menopause after surgery or medical treatment: Here's how it's different

For most women, menopause occurs naturally around the age of 49. In the lead up to menopause, the quality and quantity of eggs declines over time. Then the ovaries stop releasing eggs completely.

How painkillers can contribute to anemia in cancer patients

Researchers from the German Cancer Research Center and the University of Freiburg show how certain painkillers influence the iron metabolism of liver cancer cells and can thus contribute to iron deficiency and anemia in cancer ...

Study reveals how uterine contractions are regulated by stretch and pressure during childbirth

When labor begins, the uterus must coordinate rhythmic, well-timed contractions to deliver the baby safely. While hormones such as progesterone and oxytocin are key contributors to that process, scientists have long suspected ...

Recommended News For You

Researchers identify potential new therapeutic targets for treating T-cell lymphoma and natural killer cell tumors.

Team finds broken 'brake' on cancer mutation machine.

Eight Doctors Killed in Brazil's Horrifying Plane Crash

The pandemic had little impact on mental health symptoms.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

Survivors of high-risk neuroblastoma face substantial late effects of modern therapies

New First-Line Option for Advanced ALK-Positive Lung Cancer

Recommended Articles For You

Esophageal Cancer Survival Rates and Outcomes: Evidence-Based Insights from Oncology Studies 

How Parvovirus B19 Affects Pregnant Women and Their Unborn Babies 

Managing Hematoma: A Guide to Prevention and Treatment 

Radioligand Therapy Advances: PSMA, Neuroendocrine, and Solid Tumor Clinical Insights 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Checking PSA levels too soon after prostate cancer surgery can lead to overtreatment, study suggests

2.

Q&A: When will individuals be able to receive customized cancer vaccines?

3.

What Could This Exploratory 5-Year Survival Data in Adjuvant NSCLC Treatment Mean?

4.

AI Model Has Promise for Predicting Checkpoint Inhibitor Activity in NSCLC

5.

Data-driven risk stratification guides childhood brain tumor treatment, reducing side effects

1.

Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies

2.

Harnessing Snake Venom in Hematology: From Toxins to Life-Saving Therapeutics

3.

Unlocking the Mysteries of ICD 10 Code Normocytic Anemia

4.

Unraveling the Mystery of Non-Caseating Granulomas: A Comprehensive Guide

5.

KEYNOTE-826: Optimizing Outcomes in Persistent, Recurrent, or Metastatic Cervical Cancer

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Navigating the Complexities of Ph Negative ALL - Part III

2.

The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift

3.

Current Scenario of Cancer- An Overview of The Incidence of Cancer in Men

4.

Expert Group meeting with the management of EGFR mutation positive NSCLC - Part III

5.

Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot